Stichworte
Lungentumoren ×
Zeige mehr Stichworte
Inhaltsverzeichnis
  1. 1. Klinische Studie
  2. 2. Routinedokumentation
  3. 3. Register-/Kohortenstudien
  4. 4. Qualitätssicherung
  5. 5. Datenstandard
  6. 6. Patientenfragebogen
  7. 7. Medizinische Fachrichtung
Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

271 Suchergebnisse.

Sortieren (Relevanz) ▾

Eligibility Lung Neoplasms NCT01130753

- 27.05.18 - 1 Formular, 2 Itemgruppen, 15 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01130753

Eligibility Lung Neoplasms NCT00768131

- 27.05.18 - 1 Formular, 2 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel; ODM derived from: https://clinicaltrials.gov/show/NCT00768131

Eligibility Lung Neoplasms NCT00657423

- 27.05.18 - 1 Formular, 2 Itemgruppen, 12 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC); ODM derived from: https://clinicaltrials.gov/show/NCT00657423

Eligibility Lung Cancer NCT01657617

- 26.05.18 - 1 Formular, 2 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01657617

Eligibility Lung Cancer NCT01281787

- 26.05.18 - 1 Formular, 2 Itemgruppen, 16 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01281787

Eligibility Lung Cancer NCT01261598

- 26.05.18 - 1 Formular, 2 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Predictive Value of FDG-TEP During Radiotherapy (RT) or Chemo-radiotherapy (CRT) in Patients With Non Small Cell Lung Cancer on the One-year Survival; ODM derived from: https://clinicaltrials.gov/show/NCT01261598

Eligibility Lung Cancer NCT00989690

- 26.05.18 - 1 Formular, 1 Itemgruppe, 20 Datenelemente, 1 Sprache
Itemgruppe: Criteria
Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00989690

Eligibility Lung Cancer NCT00986297

- 26.05.18 - 1 Formular, 1 Itemgruppe, 18 Datenelemente, 1 Sprache
Itemgruppe: Criteria
Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status; ODM derived from: https://clinicaltrials.gov/show/NCT00986297

Eligibility Lung Cancer NCT00899535

- 26.05.18 - 1 Formular, 1 Itemgruppe, 17 Datenelemente, 1 Sprache
Itemgruppe: Criteria
Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030; ODM derived from: https://clinicaltrials.gov/show/NCT00899535

Eligibility Lung Cancer NCT00852644

- 26.05.18 - 1 Formular, 2 Itemgruppen, 17 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Stereotactic Radiosurgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00852644

Eligibility Lung Cancer NCT00843726

- 25.05.18 - 1 Formular, 1 Itemgruppe, 15 Datenelemente, 1 Sprache
Itemgruppe: Criteria
Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00843726

Eligibility Lung Cancer NCT00687297

- 25.05.18 - 1 Formular, 2 Itemgruppen, 21 Datenelemente, 1 Sprache
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00687297